According to Abbott Diabetes DVP, Technical Operations, Marc Taub, one in nine people in the U.S. live with diabetes. Speaking at DeviceTalks West in Santa Clara, California, he said that means everyone in the room at the time knows someone with diabetes. The condition requires constant attention and management, something Taub and Abbott aim to alleviate. […]
The biggest cardiovascular stories from TCT 2023
Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT. This year’s 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco. Usual suspects like Medtronic and Abbott released data covering a range of products, while other big names like Edwards, GE […]
Edwards wins CE mark for Mitris Resilia valve
Edwards Lifesciences announced today that it received CE mark approval for its Mitris Resilia tissue valve replacement. News of the latest regulatory milestone follows the receipt of CE mark approval for the Evoque valve system last week. Edwards also reported positive TAVR data at TCT 2023 and recorded third-quarter sales growth in its latest earnings […]
Boston Scientific stock rises on Street-beating Q3, raised EPS guidance
Boston Scientific shares ticked up today on third-quarter results that came in ahead of the consensus forecast. Shares of BSX were up slightly at $50.44 apiece by midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies —was down more than 1%. Truist analysts described the results […]
Tandem Diabetes Care has positive artificial pancreas data
Data from a Tandem Diabetes Care (Nasdaq:TNDM) study demonstrated the benefits of its automated insulin delivery technology. Diabetes Technology & Therapeutics made data available from the Control-IQ Observational (CLIO) study. It’s the largest prospective study of the Control-IQ advanced hybrid closed-loop technology to date. Twelve-month results showed, among other results, lower adverse events for type […]
Abbott has positive data for Esprit drug-eluting resorbable scaffold
Abbott today announced data supporting its Esprit BTK everolimus-eluting resorbable scaffold system. The company designed Esprit BTK to treat people with chronic limb-threatening ischemia (CLTI), a severe stage of peripheral artery disease (PAD). Abbott said its LIFE-BTK trial met both of its primary safety and effectiveness endpoints. It demonstrated the reduction of disease progression and […]
Signos raises $20M for AI-powered CGM tech with backing from Google Ventures, Dexcom Ventures
Signos announced that it raised $20 million in a Series B round to support its AI-powered continuous glucose monitor (CGM) technology. San Francisco-based Signos develops a comprehensive metabolic health platform. It includes a proprietary AI engine with a CGM to provide real-time data and recommendations for weight management. Signos aims for its metabolic-led solution to […]
Study backs left atrial appendage occlusion device from Conformal Medical
Conformal Medical announced positive one-year results from an early feasibility study of its left atrial appendage occlusion (LAAO) device. Nashua, New Hampshire-based Conformal shared the data at the 35th Transcatheter Cardiovascular Therapeutics (TCT) in San Francisco. Dr. William Gray presented the “Conformal CLAAS LAAO Device EFS 1-Year TEE Follow-Up.” “I am pleased to report that […]
5-year data supports Edwards Lifesciences’ Sapien 3 TAVR
Edwards Lifesciences announced new data demonstrating continued positive outcomes with its Sapien 3 transcatheter aortic valve replacement (TAVR). Results from the PARTNER 3 trial showed continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years. Edwards presented the data at the 35th Transcatheter Cardiovascular Therapeutics (TCT) in San Francisco. It simultaneously published […]
Abbott reports positive TriClip, MitraClip data
Abbott announced positive data for two of its minimally invasive heart devices for treating mitral and tricuspid valve disease. Results from the TRILUMINATE pivotal trial reinforced the safety and effectiveness of the TriClip system. TriClip, a transcatheter edge-to-edge repair (TEER) system, treats patients with symptomatic, severe tricuspid regurgitation (TR). Abbott also shared data from the […]
Fresenius Medical Care has a Class I recall of some hemodialysis machines
The FDA issued a notice declaring a recall of some Fresenius Medical Care hemodialysis machines as Class I, the most serious kind. Fresenius Medical Care recalled some of its 2008 Series hemodialysis machines that may cause exposure to non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs) that leach from some peroxide-cured silicone tubing used as part of […]